Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Noriko Sakasegawa"'
Autor:
Mako Wakabayashi, Seiji Futagami, Hiroshi Yamawaki, Atsushi Tatsuguchi, Keiko Kaneko, Shuhei Agawa, Kazutoshi Higuchi, Noriko Sakasegawa, Makoto Murakami, Teppei Akimoto, Yasuhiro Kodaka, Nobue Ueki, Kaya Gudis, Chiaki Kawamoto, Takashi Akamizu, Choitsu Sakamoto, Katsuhiko Iwakiri
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205165 (2018)
BACKGROUND:There was no available data concerning the clinical differentiation between the updated definition of early chronic pancreatitis (ECP) and anti-acid therapy-resistant functional dyspepsia (RFD). AIMS:We aimed to determine whether clinical
Externí odkaz:
https://doaj.org/article/18a5c91ab11944dd8c81c5786e902e83
Autor:
Kazuo Sugiyama, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Noriko Sakasegawa, Yuko Murakami, Po-Sung Chu, Shingo Usui, Yuka Ishibashi, Yuko Wakayama, Nobuhito Taniki, Hiroko Murata, Yoshimasa Saito, Masayoshi Fukasawa, Kyoko Saito, Yoshiyuki Yamagishi, Takaji Wakita, Hiroshi Takaku, Toshifumi Hibi, Hidetsugu Saito, Takanori Kanai
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94460 (2014)
Most of experiments for HCV infection have been done using lytic infection systems, in which HCV-infected cells inevitably die. Here, to elucidate metabolic alteration in HCV-infected cells in a more stable condition, we established an HCV-persistent
Externí odkaz:
https://doaj.org/article/b88f0306f3f440e2847b7f9c87059aa4
Autor:
Takashi Akamizu, Tetsuro Kawagoe, Noriko Sakasegawa, Chiaki Kawamoto, Nobue Ueki, K. Gudis, Yasuhiro Kodaka, Shuhei Agawa, Kazutoshi Higuchi, Choitsu Sakamoto, Mako Wakabayashi, Teppei Akimoto, Katsuhiko Iwakiri, Hiroshi Yamawaki, Hitomi Sato, Satomi Hashimoto, Keiko Kaneko, Katsuhisa Nakatsuka, Seiji Futagami
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
There was not available data about the overlap between functional dyspepsia (FD) and pancreatic diseases. We aimed to determine whether epigastric pain syndrome (EPS) accompanying with pancreatic enzyme abnormalities were associated with early chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46f659b150d68efd529c1b1968bb9ff
https://doi.org/10.3164/jcbn.17-41
https://doi.org/10.3164/jcbn.17-41
Autor:
Makoto Murakami, Kazutoshi Higuchi, Yasuhiro Kodaka, Nobue Ueki, Seiji Futagami, Mako Wakabayashi, Noriko Sakasegawa, Katsuhiko Iwakiri, Chiaki Kawamoto, Katya Gudis, Hiroshi Yamawaki, Keiko Kaneko, Shuhei Agawa
Publikováno v:
Digestion. 99(4)
Background/Aims: The aims of the study are to clarify the pathophysiological differences among early chronic pancreatitis (ECP), functional dyspepsia with pancreatic (FD-P) enzyme abnormalities and FD patients and to determine whether camostat mesila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a7f45baaea89a8e7e8b3cccaa1b17f
https://pubmed.ncbi.nlm.nih.gov/30391941
https://pubmed.ncbi.nlm.nih.gov/30391941
Autor:
Yasuhiro Kodaka, Noriko Sakasegawa, Shuhei Agawa, Makoto Murakami, Hiroshi Yamawaki, K. Gudis, Katsuhiko Iwakiri, Teppei Akimoto, Keiko Kaneko, Mako Wakabayashi, Chiaki Kawamoto, Seiji Futagami, Nobue Ueki, Choitsu Sakamoto, Atsushi Tatsuguchi, Takashi Akamizu, Kazutoshi Higuchi
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205165 (2018)
PLoS ONE
PLoS ONE
Background There was no available data concerning the clinical differentiation between the updated definition of early chronic pancreatitis (ECP) and anti-acid therapy-resistant functional dyspepsia (RFD). Aims We aimed to determine whether clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eefdd969b82300506f00323090d55ac
http://europepmc.org/articles/PMC6221270?pdf=render
http://europepmc.org/articles/PMC6221270?pdf=render
Autor:
Shuhei Agawa, Mako Wakabayashi, Hiroshi Yamawaki, Noriko Sakasegawa, Yasuhiro Kodaka, Kazutoshi Higuchi, Seiji Futagami, Katsuhiko Iwakiri
Publikováno v:
Therapeutic advances in chronic disease. 9(1)
Patients with functional dyspepsia, defined in the 2016 Rome IV criteria as bothersome clinical dyspepsia symptoms, experience markedly reduced quality of life. Several etiologies have been associated with the disorder. In the Rome IV criteria, the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4ec43a946bf25ef2ec1f81742551f8
https://pubmed.ncbi.nlm.nih.gov/29344328
https://pubmed.ncbi.nlm.nih.gov/29344328
Autor:
Toshifumi Hibi, Yoshimasa Saito, Masanori Ikeda, Shinya Fukuda, Noriko Sakasegawa, Ayami Sato, Hidetsugu Saito, Toshihide Muramatsu, Nobuyuki Kato, Hirotoshi Ebinuma, Kazuo Sugiyama, Masaki Kimura, Mikiko Yoneya
Publikováno v:
Journal of Cellular Biochemistry. 114:1987-1996
The histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) has a clinical promise for treatment of cancer including hepatocellular carcinoma (HCC). To investigate effect of SAHA on hepatitis C virus (HCV) replication, we treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2b5a509f024e6921608b0b376e5156f
https://doi.org/10.1002/jcb.24541
https://doi.org/10.1002/jcb.24541
Autor:
Shuhei Agawa, Mako Wakabayashi, Hiroto Noda, Noriko Sakasegawa, Go Ikeda, Katsuhiko Iwakiri, Teppei Akimoto, Hiroshi Yamawaki, Yasuhiro Kodaka, Nobue Ueki, Kumiko Kirita, Kazutoshi Higuchi, Tetsuro Kawagoe, Seiji Futagami
Publikováno v:
Translational Gastroenterology and Hepatology. 3:70-70
Functional dyspepsia (FD) is one of the gastrointestinal disorders and can be severely disturbed with quality of life (QOL). Visceral hypersensitivity (1), disturbed gastric accommodation (2) and disturbed gastric motility are mostly reported in FD p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565e921ef27856bca0f1b4ed8364331a
https://doi.org/10.21037/tgh.2018.09.12
https://doi.org/10.21037/tgh.2018.09.12
Autor:
Ayami, Sato, Yoshimasa, Saito, Kazuo, Sugiyama, Noriko, Sakasegawa, Toshihide, Muramatsu, Shinya, Fukuda, Mikiko, Yoneya, Masaki, Kimura, Hirotoshi, Ebinuma, Toshifumi, Hibi, Masanori, Ikeda, Nobuyuki, Kato, Hidetsugu, Saito
Publikováno v:
Journal of cellular biochemistry. 114(9)
The histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) has a clinical promise for treatment of cancer including hepatocellular carcinoma (HCC). To investigate effect of SAHA on hepatitis C virus (HCV) replication, we treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c043946066ada45d0c3f7b41326b8d19
https://pubmed.ncbi.nlm.nih.gov/23519646
https://pubmed.ncbi.nlm.nih.gov/23519646
Autor:
Yuka Ishibashi, Nobuhiro Nakamoto, Nobuhito Taniki, Noriko Sakasegawa, Kyoko Saito, Po Sung Chu, Shingo Usui, Yuko Murakami, Hiroshi Takaku, Masayoshi Fukasawa, Kazuo Sugiyama, Toshifumi Hibi, Hirotoshi Ebinuma, Takaji Wakita, Yuko Wakayama, Takanori Kanai, Yoshimasa Saito, Hiroko Murata, Yoshiyuki Yamagishi, Hidetsugu Saito
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94460 (2014)
PLoS ONE
PLoS ONE
Most of experiments for HCV infection have been done using lytic infection systems, in which HCV-infected cells inevitably die. Here, to elucidate metabolic alteration in HCV-infected cells in a more stable condition, we established an HCV-persistent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4811c38d956017b744887627703e15
https://doi.org/10.1371/journal.pone.0094460
https://doi.org/10.1371/journal.pone.0094460